Aimmune Therapeutics, Inc. (Nasdaq: AIMT) announced that Nestlé Health Science will make a $145.0 million equity investment in Aimmune. Aimmune ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE